title: Belimumab after rituximab as maintenance therapy in lupus nephritis.
authors.affiliation: Department of Nephrology and Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Tineke
authors.initials: T
authors.lastname: Kraaij
authors.affiliation: Department of Nephrology and Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Tom W J
authors.initials: TW
authors.lastname: Huizinga
authors.affiliation: Department of Nephrology and Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Ton J
authors.initials: TJ
authors.lastname: Rabelink
authors.affiliation: Department of Nephrology and Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. y.k.o.teng@lumc.nl.
authors.forename: Y K Onno
authors.initials: YK
authors.lastname: Teng
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018951:Antigens, CD20; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008181:Lupus Nephritis / Q000188:drug therapy*; D008297:Male; D000069283:Rituximab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D007155:Immunologic Factors; D000069283:Rituximab; C511911:belimumab